+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sodium Oxybate Oral Solution Market - Global Forecast 2026-2032- Product Image
Sodium Oxybate Oral Solution Market - Global Forecast 2026-2032- Product Image
Sale

Sodium Oxybate Oral Solution Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125185
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sodium Oxybate Oral Solution Market is projected to reach USD 626.34 Million in 2026. It is expected to continue growing at a CAGR of 7.68%, reaching USD 974.05 Million by 2032.

Sodium Oxybate Oral Solution: Executive Overview

Sodium oxybate oral solution is a prescription central nervous system depressant used primarily for narcolepsy-related cataplexy and excessive daytime sleepiness. Its clinical value is linked to symptom control, sleep architecture, and treatment adherence, while its handling requirements reflect important safety and misuse considerations. The market is shaped by regulatory controls, specialist prescribing, patient-monitoring obligations, and the availability of approved formulations and distribution channels.

Safety Controls and Treatment Access Are Reshaping the Landscape

The landscape is being transformed by tighter risk-management expectations, controlled-substance oversight, and greater emphasis on verified dispensing and patient education. Oral-liquid dosing can support individualized administration but also increases the importance of accurate measuring devices, clear instructions, secure storage, and caregiver awareness. Access is additionally influenced by specialist diagnosis, reimbursement policies, supply continuity, and the development of alternative narcolepsy treatments with different administration and tolerability profiles.

Artificial Intelligence Strengthens Diagnosis, Monitoring, and Adherence Support

Artificial intelligence can contribute to earlier recognition of narcolepsy by analyzing sleep diaries, symptom patterns, wearable data, and clinical records, although diagnostic conclusions require qualified clinical assessment. Predictive tools may help identify adherence risks, dosing inconsistencies, adverse-event signals, and patients needing follow-up. For sodium oxybate oral solution, practical applications include medication reminders, dispensing verification, patient-facing education, and pharmacovigilance triage. Effective deployment depends on validated datasets, privacy safeguards, explainability, and human oversight, particularly because treatment involves a controlled medicine and clinically significant safety risks.

Regional Insights: Regulation and Specialist Capacity Define Access

North America generally combines established sleep-medicine infrastructure with structured controlled-substance requirements, while Latin America may experience more uneven diagnosis, reimbursement, and specialist access. Europe is shaped by national health systems, European regulatory coordination, and country-specific prescribing and reimbursement decisions. The Middle East shows variation in specialist availability and healthcare-system maturity, and Africa faces substantial gaps in diagnostic capacity, continuity of supply, and affordability. Asia-Pacific presents diverse conditions: Australia, Japan, and South Korea have comparatively developed specialist pathways, whereas access across other markets can be more dependent on urban healthcare capacity, regulatory approvals, and local reimbursement arrangements.

Group Insights: Economic and Regulatory Blocs Create Different Access Conditions

ASEAN markets differ considerably in regulatory maturity, specialist coverage, and medicine reimbursement, making regional harmonization and local evidence important. BRICS countries span highly diverse healthcare systems and controlled-medicine frameworks, with access influenced by domestic manufacturing, public procurement, and specialist distribution. The European Union benefits from shared regulatory structures but retains national decisions on pricing, reimbursement, and care delivery. G7 members generally have mature clinical infrastructure and pharmacovigilance systems, while NATO members display varied healthcare models despite cooperation in broader medicines resilience. GCC countries often have concentrated specialist services, centralized procurement practices, and strong regulatory oversight, with access patterns differing between individual member states.

Country Insights: National Policies and Clinical Infrastructure Shape Utilization

Australia has established sleep-health services but must address geographic access and controlled-medicine stewardship. Brazil and Mexico face variation in specialist availability, reimbursement, and diagnosis across public and private care. Canada and the United States have sophisticated narcolepsy-care pathways, with access shaped by authorization, insurance design, and risk-management requirements. China and India are expanding clinical capacity but show substantial regional differences in diagnosis, specialist coverage, and affordability. Japan and South Korea have advanced healthcare systems with distinct regulatory and prescribing practices. France, Germany, Italy, and Spain combine specialist expertise with nationally specific reimbursement and prescribing processes. The United Kingdom relies on specialized services and public-system commissioning, while Russia’s access is influenced by national regulation, supply conditions, and regional healthcare disparities.

Action Priorities for Leaders: Build Safe, Resilient, Patient-Centered Access

Industry leaders should prioritize compliant patient-support programs that reinforce dosing accuracy, secure storage, treatment expectations, and timely clinical review. Supply strategies should include qualified manufacturing capacity, resilient distribution, inventory visibility, and contingency planning for controlled medicines. Evidence generation should focus on real-world adherence, functional outcomes, safety, health-system burden, and patient-reported experience across diverse populations. Leaders should also invest in interoperable monitoring tools, transparent AI governance, privacy protection, and partnerships with sleep specialists, pharmacists, payers, and patient organizations. Market access planning should remain country-specific and align with local authorization, reimbursement, and controlled-substance requirements.

Research Methodology: Evidence-Based Assessment of the Treatment Environment

This executive summary uses a structured qualitative assessment of sodium oxybate oral solution across clinical use, safety controls, regulation, healthcare delivery, reimbursement, distribution, and technology adoption. Regional, group, and country comparisons are organized around publicly verifiable institutional factors, including regulatory frameworks, specialist-care capacity, controlled-medicine policies, and health-system characteristics. No market estimates, market sizes, market shares, forecasts, or company-specific claims are used. Interpretation should be validated against current national labels, regulatory decisions, clinical guidance, reimbursement rules, and supply information before operational decisions are made.

Conclusion: Responsible Stewardship Is Central to Sustainable Access

Sodium oxybate oral solution occupies a clinically important but highly regulated position in narcolepsy care. Its future access will depend less on product availability alone than on accurate diagnosis, specialist oversight, responsible dispensing, patient adherence, and resilient supply systems. Regional and national differences require tailored implementation, while artificial intelligence can support-not replace-clinical judgment and safety governance. Leaders that combine evidence-based care, disciplined risk management, and patient-centered service design will be best positioned to improve appropriate treatment access.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sodium Oxybate Oral Solution Market, by Product Type
7.1. Introduction
7.2. Brand Xyrem
7.3. Brand Xywav
7.4. Generic
8. Sodium Oxybate Oral Solution Market, by Indication
8.1. Introduction
8.2. Narcolepsy With Cataplexy
8.3. Narcolepsy Without Cataplexy
8.4. Off Label Use
9. Sodium Oxybate Oral Solution Market, by Patient Age Group
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Sodium Oxybate Oral Solution Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care Settings
10.4. Hospitals
10.5. Specialty Sleep Centers
11. Sodium Oxybate Oral Solution Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Sodium Oxybate Oral Solution Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Sodium Oxybate Oral Solution Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Sodium Oxybate Oral Solution Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alembic Pharmaceuticals Limited
16.2. Amneal Pharmaceuticals, Inc.
16.3. Aurobindo Pharma Limited
16.4. Cipla Limited
16.5. Dr. Reddy's Laboratories Ltd.
16.6. Glenmark Pharmaceuticals Ltd.
16.7. Hetero Labs Limited
16.8. Hikma Pharmaceuticals PLC
16.9. Jazz Pharmaceuticals plc
16.10. Lannett Company, Inc.
16.11. Lupin Limited
16.12. Macleods Pharmaceuticals Ltd.
16.13. Mylan N.V.
16.14. Natco Pharma Limited
16.15. Novartis AG
16.16. Strides Pharma Science Limited
16.17. Sun Pharmaceutical Industries Ltd.
16.18. Teva Pharmaceutical Industries Ltd.
16.19. Torrent Pharmaceuticals Ltd.
16.20. Zydus Lifesciences Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Sodium Oxybate Oral Solution Market, Years Considered for the Study
FIGURE 2. Global Sodium Oxybate Oral Solution Market, Research Design
FIGURE 3. Global Sodium Oxybate Oral Solution Market, Research Framework
FIGURE 4. Global Sodium Oxybate Oral Solution Market, Data Triangulation
FIGURE 5. Global Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Sodium Oxybate Oral Solution Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Sodium Oxybate Oral Solution Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Sodium Oxybate Oral Solution Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Sodium Oxybate Oral Solution Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Sodium Oxybate Oral Solution Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Sodium Oxybate Oral Solution Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Sodium Oxybate Oral Solution Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Sodium Oxybate Oral Solution Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Sodium Oxybate Oral Solution Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Sodium Oxybate Oral Solution Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Sodium Oxybate Oral Solution Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Sodium Oxybate Oral Solution Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Sodium Oxybate Oral Solution Market Segmentation & Coverage
TABLE 2. Global Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 3. Global Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Brand Xyrem Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Brand Xyrem Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Brand Xyrem Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Brand Xywav Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Brand Xywav Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Brand Xywav Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 14. Global Narcolepsy With Cataplexy Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Narcolepsy With Cataplexy Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Narcolepsy With Cataplexy Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Narcolepsy Without Cataplexy Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Narcolepsy Without Cataplexy Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Narcolepsy Without Cataplexy Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Off Label Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Off Label Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Off Label Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 24. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 34. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Specialty Sleep Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Specialty Sleep Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Specialty Sleep Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 47. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Sodium Oxybate Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Sodium Oxybate Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 60. North America Sodium Oxybate Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. North America Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. North America Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 63. North America Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 64. North America Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. North America Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 66. Latin America Sodium Oxybate Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Latin America Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. Latin America Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 69. Latin America Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 70. Latin America Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Latin America Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Europe Sodium Oxybate Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Europe Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 74. Europe Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 75. Europe Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 76. Europe Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Europe Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Middle East Sodium Oxybate Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Middle East Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 80. Middle East Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 81. Middle East Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 82. Middle East Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Middle East Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Africa Sodium Oxybate Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Africa Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Africa Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 87. Africa Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 88. Africa Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Africa Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Global Sodium Oxybate Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. ASEAN Sodium Oxybate Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. ASEAN Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. ASEAN Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 94. ASEAN Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 95. ASEAN Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. ASEAN Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. GCC Sodium Oxybate Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. GCC Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. GCC Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 100. GCC Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 101. GCC Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. GCC Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. European Union Sodium Oxybate Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. European Union Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. European Union Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 106. European Union Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 107. European Union Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. European Union Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. BRICS Sodium Oxybate Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. BRICS Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. BRICS Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 112. BRICS Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 113. BRICS Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. BRICS Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. G7 Sodium Oxybate Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. G7 Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. G7 Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 118. G7 Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 119. G7 Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. G7 Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. NATO Sodium Oxybate Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. NATO Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. NATO Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 124. NATO Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 125. NATO Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. NATO Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Global Sodium Oxybate Oral Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. United States Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 129. United States Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. United States Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 131. United States Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 132. United States Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. United States Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Canada Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 135. Canada Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. Canada Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 137. Canada Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 138. Canada Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Canada Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. Mexico Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 141. Mexico Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. Mexico Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 143. Mexico Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 144. Mexico Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Mexico Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Brazil Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 147. Brazil Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. Brazil Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 149. Brazil Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 150. Brazil Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Brazil Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. United Kingdom Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 153. United Kingdom Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. United Kingdom Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 155. United Kingdom Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 156. United Kingdom Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. United Kingdom Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. Germany Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 159. Germany Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. Germany Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 161. Germany Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 162. Germany Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Germany Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. France Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 165. France Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. France Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 167. France Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 168. France Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. France Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Russia Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 171. Russia Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Russia Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 173. Russia Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 174. Russia Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Russia Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. Italy Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 177. Italy Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. Italy Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 179. Italy Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 180. Italy Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Italy Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Spain Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 183. Spain Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Spain Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 185. Spain Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 186. Spain Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Spain Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. China Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 189. China Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. China Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 191. China Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 192. China Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. China Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. India Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 195. India Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. India Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 197. India Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 198. India Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. India Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Japan Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 201. Japan Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Japan Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 203. Japan Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 204. Japan Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Japan Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Australia Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 207. Australia Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. Australia Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 209. Australia Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 210. Australia Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Australia Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. South Korea Sodium Oxybate Oral Solution Market Size, 2017-2032 (USD Million)
TABLE 213. South Korea Sodium Oxybate Oral Solution Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. South Korea Sodium Oxybate Oral Solution Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. South Korea Sodium Oxybate Oral Solution Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 216. South Korea Sodium Oxybate Oral Solution Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. South Korea Sodium Oxybate Oral Solution Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Global Sodium Oxybate Oral Solution Market Share, by Key Player, 2025
TABLE 219. Global Sodium Oxybate Oral Solution Market, Key Experts

Companies Mentioned

  • Alembic Pharmaceuticals Limited
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Hikma Pharmaceuticals PLC
  • Jazz Pharmaceuticals plc
  • Lannett Company, Inc.
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • Mylan N.V.
  • Natco Pharma Limited
  • Novartis AG
  • Strides Pharma Science Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Sodium Oxybate Oral Medications Market - Global Forecast 2026-2032 - Product Image

Sodium Oxybate Oral Medications Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Narcolepsy Treatment Market - Global Forecast 2026-2032 - Product Image

Narcolepsy Treatment Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Global Narcolepsy Drugs Market Report by Disease Type, Therapeutic Type, End Users, Country and Company Analysis 2026-2034 - Product Image

Global Narcolepsy Drugs Market Report by Disease Type, Therapeutic Type, End Users, Country and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Narcolepsy Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Narcolepsy Market Report 2026 - Product Image

Narcolepsy Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.